Roivant Sciences (ROIV) director uses stock to cover tax bill
Roivant Sciences (ROIV) director Melissa B. Epperly had 2,179 shares withheld for tax obligations on September 10, 2026, leaving her with 14,838 shares. The shares were withheld at $40.94 per share to cover taxes on vested equity awards.
How this was made
The 30-second read
Why it matters
The filing provides transparency but carries negligible price impact.
Market read
Routine insider tax‑withholding; low trading relevance.
What to watch
Potential future insider sales or purchases could be more material; monitor subsequent Form 4 filings.
Background
SEC Form 4 filing discloses a tax‑withholding disposition by a non‑employee director of Roivant Sciences.
Ticker impact
Director Melissa B. Epperly had 2,179 ROIV shares withheld for tax on Sep 10, 2026 at $40.94 per share ($89K).
Minimal to none; market may view as routine insider filing.
The transaction size ($89K) is trivial for a mid‑cap listed company and represents a standard tax settlement, not a buy or sell pressure.
Market effects
None; the filing is specific to Roivant and does not affect the broader biotech sector.
None; the event is confined to a single US‑listed company.
None
Counterpoint
If the director retains a sizable stake after the withholding, it could signal confidence, but the amount is too small to infer.
Key entities
- DirectorMelissa B. Epperly
Non‑employee director of Roivant Sciences who performed the tax‑withholding transaction.
- CompanyRoivant Sciences
Biotech company listed on Nasdaq under ticker ROIV.
